Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alexandra, Shillingburg"'
Autor:
Brandi Anders, Lauren Veltri, Abraham S. Kanate, Alexandra Shillingburg, Nilay Shah, Michael Craig, Aaron Cumpston
Publikováno v:
Advances in Hematology, Vol 2017 (2017)
Relapsed/refractory acute myeloid leukemia (RR-AML) is associated with poor prognosis and long-term disease-free survival requires allogeneic hematopoietic cell transplantation (allo-HCT). Limited data exists, regarding the optimal regimen to obtain
Externí odkaz:
https://doaj.org/article/37d1ffd720d1401581edefbd9de5c27c
Autor:
Rebecca Moses, Laura F. Gibson, Aaron W. Stewart, Aaron Cumpston, Alexandra Shillingburg, William P. Petros, Debra Piktel, Michael Craig, Sijin Wen
Publikováno v:
PharmacotherapyREFERENCES. 42(1)
Introduction Filgrastim is a human granulocyte colony-stimulating factor (G-CSF). There is limited data on dosing filgrastim in obesity. The objective of this study was to compare filgrastim pharmacokinetic parameters for morbidly obese and non-obese
Autor:
Jaime Anderson, Alexandra Shillingburg, David W. Henry, Rowena Schwartz, Laura Boehnke Michaud
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:175-186
Gender disparity exists in leadership roles within healthcare. While the majority of the healthcare workforce is comprised of women, significantly fewer women occupy leadership positions, particularly at executive and board levels. As the field of on
Autor:
Hillary Prescott, Julie Kennerly-Shah, Christopher T Elder, Alexandra Shillingburg, Bhavesh Shah, Michael J Reff
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:156-174
The development of BCR-ABL-targeting tyrosine kinase inhibitors has transformed chronic phase chronic myeloid leukemia (CP CML) from a disease with a terminal prognosis to a treatable chronic illness. Long-term treatment with tyrosine kinase inhibito
Autor:
Alexandra Shillingburg, Aaron Cumpston, Abraham S. Kanate, Michael Craig, Sijin Wen, Mehdi Hamadani
Publikováno v:
Supportive Care in Cancer. 25:2215-2219
Mucositis is a significant complication of intensive chemotherapy or hematopoietic cell transplantation (HCT), with few treatment options. Ketamine mouthwashes have been used for pain relief, but supporting evidence is limited. The primary objective
Autor:
Michael Newton, Matthew Snyder, Alexandra Shillingburg, Michael Craig, Aaron Cumpston, Abraham S. Kanate, Mehdi Hamadani
Publikováno v:
Supportive Care in Cancer. 24:4237-4240
For an outpatient cancer center to operate efficiently, optimizing the use of chair time is essential. Allogeneic hematopoietic cell transplant (allo-HCT) recipients are seen frequently in this setting after hospital discharge and regularly for sever
Publikováno v:
Chemotherapy Research and Practice
The study was undertaken to determine the length of time between when a prescription for an oral antineoplastic agent is written by the provider and when the medication is received by the patient and to identify risk factors that significantly increa
Autor:
Nilay A. Shah, Michael Craig, Xiaoxiao Lu, Sijin Wen, Morgan Belling, Aaron Cumpston, Alexandra Shillingburg, Abraham S. Kanate
Publikováno v:
Leukemia Research and Treatment
BASE-Bielefeld Academic Search Engine
BASE-Bielefeld Academic Search Engine
Posaconazole (PCZ) is frequently used for prophylaxis against invasive fungal infections (IFI) in patients undergoing induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Posaconazole is commercially available as
Autor:
Michael Craig, Abraham S. Kanate, Alexandra Shillingburg, Brandi Anders, Aaron Cumpston, Nilay A. Shah, Lauren Veltri
Publikováno v:
Advances in Hematology, Vol 2017 (2017)
Advances in Hematology
Advances in Hematology
Relapsed/refractory acute myeloid leukemia (RR-AML) is associated with poor prognosis and long-term disease-free survival requires allogeneic hematopoietic cell transplantation (allo-HCT). Limited data exists, regarding the optimal regimen to obtain
Autor:
Lisa Biondo, Alexandra Shillingburg
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 19:127-131
OBJECTIVE: To describe the use of aprepitant and fosaprepitant, a neurokinin 1 (NK-1) receptor inhibitor, in children and adolescents at a large academic medical center, for the prevention and management of chemotherapy-induced nausea and vomiting (C